Drug General Information |
Drug ID |
D0A1QJ
|
Former ID |
DNC001421
|
Drug Name |
Tellurium
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
Te
|
Canonical SMILES |
[Te]
|
InChI |
1S/Te
|
InChIKey |
PORWMNRCUJJQNO-UHFFFAOYSA-N
|
CAS Number |
CAS 11073-85-1
|
PubChem Compound ID |
|
PubChem Substance ID |
6233131, 7890735, 8020366, 10514260, 11600289, 15388371, 16410393, 24852275, 24855962, 24855963, 24856041, 24856140, 24868693, 24888604, 42974933, 49658636, 49854958, 50049620, 51075757, 56371253, 57365914, 77578376, 93618388, 114449275, 117682981, 118309590, 126672821, 134340529, 134340607, 134991308, 135268760, 137001630, 137171626, 137240393, 140202937, 143435218, 143472660, 143801827, 160649668, 162094955, 162271686, 162474255, 163802217, 164847921, 175266061, 176269486, 179692759, 184609360, 198988129, 204359562
|
Target and Pathway |
Target(s) |
Squalene monooxygenase |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Steroid biosynthesis
|
Sesquiterpenoid and triterpenoid biosynthesis
|
Metabolic pathways
|
Biosynthesis of secondary metabolites
|
Biosynthesis of antibiotics
|
PathWhiz Pathway
|
Steroid Biosynthesis
|
Reactome
|
Cholesterol biosynthesis
|
Activation of gene expression by SREBF (SREBP)
|
References |
REF 1 | Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res. 2003 Jan;42(1):37-50. |